Evidence map›Paper›PMID 36341397›Full record

ArticleFrontiers in immunology2022

Downregulation of the vitamin D receptor expression during acute gastrointestinal graft versus host disease is associated with poor outcome after allogeneic stem cell transplantation.

Carina Matos, Andreas Mamilos, Pranali N Shah, Elisabeth Meedt, Daniela Weber, Saroj Ghimire, Andreas Hiergeist, André Gessner, Anne Dickinson, Ralf Dressel and 10 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 5 institutions in 4 countries.

Carina MatosDepartment of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.
Andreas MamilosDepartment of Pathology, University of Regensburg, Regensburg, Germany.
Pranali N ShahDepartment of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.
Elisabeth MeedtDepartment of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.
Daniela WeberDepartment of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.
Saroj GhimireKathmandu University School of Medical Sciences, Dhulikhel, Nepal.
Andreas HiergeistInstitute of Clinical Microbiology and Hygiene, University Hospital Regensburg, Regensburg, Germany.
André GessnerInstitute of Clinical Microbiology and Hygiene, University Hospital Regensburg, Regensburg, Germany.
Anne DickinsonTranslational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom.
Ralf DresselInstitute of Cellular and Molecular Immunology, University Medical Centre Göttingen, Göttingen, Germany.
Lutz WalterPrimate Genetics Laboratory, German Primate Center, Leibniz-Institute for Primate Research, Göttingen, Germany.
Klaus StarkDepartment for Genetic Epidemiology, University of Regensburg, Regensburg, Germany.
Iris M HeidDepartment for Genetic Epidemiology, University of Regensburg, Regensburg, Germany.
Hendrik PoeckDepartment of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.
Matthias EdingerDepartment of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.
Daniel WolffDepartment of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.
Wolfgang HerrDepartment of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.
Ernst HollerDepartment of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.
Marina KreutzDepartment of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.
Sakhila GhimireDepartment of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.
University Hospital Regensburg · DEGerman Primate Center · DEUniversity of Regensburg · DEBrigham and Women's Hospital · USNewcastle University · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The vitamin D receptor (VDR) is critical in regulating intestinal homeostasis and emerging evidence demonstrates that VDR deficiency is a critical factor in inflammatory bowel disease pathology. However, no clinical data exist regarding the intestinal expression of VDR in patients after allogeneic haematopoietic stem cell transplantation (HSCT). Analyzing intestinal biopsies from 90 patients undergoing HSCT with mortality follow-up, we demonstrated that patients with severe acute gastrointestinal graft versus host disease (GI-GvHD) showed significant downregulation of VDR gene expression compared to mild or no acute GI-GvHD patients (p = 0.007). Reduced VDR expression was already detectable at acute GI-GvHD onset compared to GvHD-free patients (p = 0.01). These results were confirmed by immunohistochemistry (IHC) where patients with severe acute GI-GvHD showed fewer VDR+ cells (p = 0.03) and a reduced VDR staining score (p = 0.02) as compared to mild or no acute GI-GvHD patients. Accordingly, low VDR gene expression was associated with a higher cumulative incidence of treatment-related mortality (TRM) (p = 1.6x10-6) but not with relapse-related mortality (RRM). A multivariate Cox regression analysis identified low VDR as an independent risk factor for TRM (p = 0.001, hazard ratio 4.14, 95% CI 1.78-9.63). Furthermore, VDR gene expression significantly correlated with anti-microbial peptides (AMPs) gene expression (DEFA5: r = 0.637, p = 7x10-5, DEFA6: r 0 0.546, p = 0.001). In conclusion, our findings suggest an essential role of the VDR in the pathogenesis of gut GvHD and the prognosis of patients undergoing HSCT.

Indexed as

Graft vs Host DiseaseHematopoietic Stem Cell TransplantationAcute DiseaseDown-RegulationHumansReceptors, CalcitriolReceptors, Calcitriolacute GI-GvHDdefensinsHSCTTRMVDR

Identifiers

PMID36341397
PMCPMC9632171
OpenAlexW4306873878

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.